Genmab A (GMAB) Finished Goods (2023 - 2025)

Genmab A (GMAB) has reported Finished Goods for 3 consecutive years, with $13.0 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Finished Goods rose 76.86% year-over-year to $13.0 million; the trailing twelve-month figure through Dec 2025 stood at $13.0 million (up 76.86% YoY), and the FY2025 full-year result was $13.0 million, up 18.18% from the prior year.
• Finished Goods rose to $13.0 million in Q4 2025 per GMAB's latest filing, from $7.4 million in the prior quarter.
• Across five years, Finished Goods topped out at $13.0 million in Q4 2025 and bottomed at $5.5 million in Q4 2023.
• Historically, Finished Goods has averaged $8.6 million across 3 years, with a median of $7.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Finished Goods jumped 32.61% in 2024, then soared 76.86% in 2025.
• Over 3 years, Finished Goods stood at $5.5 million in 2023, then surged by 32.61% to $7.4 million in 2024, then surged by 76.86% to $13.0 million in 2025.
• According to Business Quant data, Finished Goods over the past three periods registered $13.0 million, $7.4 million, and $5.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.